Mandeg, Chelly G.
HRN: 23-05-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/29/2024
05/05/2024
IV
220mg
Q6
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes